Expectant Management of Preterm Premature Rupture of Membranes (PPROM) at 36 Weeks

Guideline Recommendation (Royal College of Obstetricians and Gynaecologists)

• Women with PPROM after 24 + 0 weeks gestation who have no contraindications should be offered expectant management until 37 + 0 weeks, supported by Grade A evidence from the RCOG. 1

Antibiotic Therapy

• Initiate erythromycin 250 mg orally four times daily immediately after PPROM and continue for 10 days or until labor begins, whichever occurs first. (RCOG recommendation) 1
• If erythromycin is not tolerated, penicillin can be used as an alternative antibiotic. 5
• Co‑amoxiclav should be avoided because it is associated with an increased risk of neonatal necrotizing enterocolitis. 5

Antenatal Corticosteroid Consideration

• Antenatal corticosteroids are recommended between 34 + 0 and 35 + 6 weeks (Grade A), but at 36 weeks the benefit‑to‑risk ratio is less favorable; steroids are generally not indicated unless delivery is imminent. (RCOG guidance) 5

Infection Surveillance

• Monitor for infection using a combination of clinical assessment, maternal C‑reactive protein, white‑blood‑cell count, and fetal heart‑rate patterns; no single parameter should be used in isolation to diagnose chorioamnionitis. (RCOG protocol) 1

Latency and Neonatal Outcomes

• The median latency period after PPROM is about 7 days and shortens as gestational age advances. (Observational data) 1
• Allowing an additional week to reach 37 weeks reduces neonatal respiratory morbidity associated with late‑preterm birth. (RCOG evidence) 2
• Extending expectant management to 37 weeks also decreases the need for neonatal intensive‑care admission. (RCOG evidence) 2

Contraindications Requiring Immediate Delivery

• Clinical chorioamnionitis (fever, maternal tachycardia, fetal tachycardia, uterine tenderness, purulent discharge). 1
• Non‑reassuring fetal status. 2
• Placental abruption. 2
• Cord prolapse. 2
• Maternal sepsis. 1

Clinical Decision‑Making and Patient Communication

• Timing of birth should be individualized; discuss the benefits and risks of expectant management versus earlier delivery with each woman, incorporating her preferences. (RCOG recommendation) 1
• Isolated elevation of inflammatory markers without accompanying clinical signs should not trigger immediate delivery; rely on the combined assessment approach described above. (RCOG guidance) 1